UPDATE: Oppenheimer Downgrades Body Central Corp. (BODY) to Perform; Second Downward Revision Moves Us To Sidelines

June 19, 2012 7:17 AM EDT Send to a Friend
Get Alerts BODY Hot Sheet
Price: $2.60 -9.41%

Rating Summary:
    1 Buy, 5 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 8 | Down: 12 | New: 23
Trade BODY Now!
Join SI Premium – FREE
(Updated - June 19, 2012 10:47 AM EDT)

Oppenheimer downgraded Body Central Corp. (NASDAQ: BODY) from Outperform to Perform.

Analyst, Pamela Quintiliano, said, "BODY downwardly revised guidance for the second time in as many months (recall on May 3rd first took down in conjunction with 1Q report). Unfortunately since then June-to-date has experienced a broad-based deceleration resulting in above-plan markdowns and significant gross margin pressure. Issues are not expected to be resolved until mid-3Q at the earliest. As such, prefer to take a wait-and-see approach..."

Oppenheimer lowers FY12 EOS estimate from $1.38 to $1.07 and FY13 from $1.70 to $1.40.

For an analyst ratings summary and ratings history on Body Central Corp. click here. For more ratings news on Body Central Corp. click here.

Shares of Body Central Corp. closed at $8.22 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst EPS Change, Analyst EPS View, Downgrades

Add Your Comment